← Open Payments lookup

JACQUELINE GALDOS: Open Payments

NPI 1477213718 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,286 in 42 payments from 17 companies in 2025. Trend: 2023 $123 · 2024 $976 · 2025 $1,286

Food & beverage: $1,192Education: $94
CompanyPaymentsAmount
Janssen Biotech, Inc.10$258
Astellas Pharma US Inc5$162
ABBVIE INC.2$152
Takeda Pharmaceuticals U.S.A., Inc.4$123
Celgene Corporation4$118
Syndax Pharmaceuticals, Inc.3$99
Incyte Corporation3$84
Daiichi Sankyo Inc.2$48
PFIZER INC.1$35
Novartis Pharmaceuticals Corporation1$30

Products named: VENCLEXTA, CARVYKTI, REBLOZYL, DARZALEX, Xospata, TALVEY, LIVTENCITY, MONJUVI.

Industry payments across DC — which companies pay providers there.